BeStock  
Stocks › Medical Devices › IART

Integra Lifesciences IART

US equityMarket cap rank #3233Medical DevicesBrain-Computer Interface
$13.00 −$0.32 (-2.40%)
Pre-market · Oct 8, 8:20 am ET · After hours $13.00 0.00%
Open$13.19
Prev close$13.32
Day range$12.98 – $13.46
Volume1.41M
Market cap$1.01B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$418.76M+0.8% YoY
Operating profit$19.29M+1,573.3% YoY
Net profit$4.48M+100.9% YoY
Diluted EPS$0.06+101.0% YoY
Free cash flow$10.50M+193.5% YoY
Operating cash flow$22.80M

Revenue, last 8 quarters

$380.8MSep '24$442.6MDec '24$382.7MMar '25$415.6MJun '25$402.1MSep '25$434.9MDec '25$391.9MMar '26$418.8MJun '26

Net profit, last 8 quarters

$-10.7MSep '24$19.4MDec '24$-25.3MMar '25$-484.1MJun '25$-5.4MSep '25$-1.7MDec '25$-4.6MMar '26$4.5MJun '26

Diluted EPS by quarter

-0.14Sep '240.25Dec '24-0.33Mar '25-6.31Jun '25-0.07Sep '25-0.02Dec '25-0.06Mar '260.06Jun '26

Free cash flow by quarter

$-7.2MSep '24$11.2MDec '24$-40.2MMar '25$-11.2MJun '25$25.8MSep '25$-19.6MDec '25$-5.0MMar '26$10.5MJun '26

Annual revenue

$1.4BFY20$1.5BFY21$1.6BFY22$1.5BFY23$1.6BFY24$1.6BFY25

Profitability & balance sheet

Gross margin52.5%
Operating margin4.0%
Net margin-0.4%
Return on equity-0.7%
Return on assets-0.2%
Return on invested capital1.2%
Current ratio3.60
Liabilities / assets70.7%
Cash & investments$274.08M
Total debt$2.03B
Net cash (debt)-$1.76B
Free cash flow / sales0.7%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Specialty Surgery$309.27M 73.9%
  • Tissue Reconstruction$109.49M 26.1%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $418.76M $391.92M $1.64B $434.93M $402.06M
Total Operating Revenue $418.76M $391.92M $1.64B $434.93M $402.06M
Cost of Revenue $199.02M $174.94M $803.63M $214.06M $195.07M
Gross Profit $219.74M $216.98M $831.62M $220.87M $206.99M
Operating Expense $200.46M $205.51M $813.63M $197.83M $195.23M
Selling and Admin Expenses $172.44M $178.24M $699.70M $169.27M $169.05M
Research & Development $24.25M $23.50M $98.97M $24.79M $22.46M
Depreciation & Amortization & Depletion $3.77M $3.78M $14.95M $3.77M $3.73M
-Depreciation & Amortization $3.77M $3.78M $14.95M $3.77M $3.73M
Operating Profit $19.29M $11.47M $18.00M $23.04M $11.76M
Net Non-Operating Interest Income (Expense) -$18.73M -$18.36M -$67.78M -$19.31M -$17.74M
Non-Operating Interest Income $4.27M $4.11M $18.47M $4.36M $4.98M
Non-Operating Interest Expense $22.99M $22.47M $86.26M $23.67M $22.73M
Other Income (Expense) $4.19M $4.48M -$513.72M $581,000.00 -$842,000.00
Special Income (Charges) $0.00 – -$511.37M $0.00 $0.00
-Less:Impairment of Capital Assets $0.00 – $511.37M $0.00 $0.00
Other Non-Operating Income (Expenses) $4.19M $4.48M -$2.35M $581,000.00 -$842,000.00
Pretax Profit $4.74M -$2.41M -$563.50M $4.31M -$6.82M
Tax $262,000.00 $2.21M -$47.03M $6.01M -$1.42M
Net Profit $4.48M -$4.62M -$516.47M -$1.70M -$5.40M
Profit from Continuing Operations $4.48M -$4.62M -$516.47M -$1.70M -$5.40M
Net Income to Parent Company $4.48M -$4.62M -$516.47M -$1.70M -$5.40M
Net Income to Common Stockholders $4.48M -$4.62M -$516.47M -$1.70M -$5.40M
Basic EPS $0.06 -$0.06 -$6.74 -$0.02 -$0.07
Diluted EPS $0.06 -$0.06 -$6.74 -$0.02 -$0.07

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $3.56B $3.58B $3.60B $3.60B $3.65B
Total Current Assets $1.19B $1.17B $1.16B $1.16B $1.14B
Cash and Cash Equivalents & Short-Term Investments $274.08M $265.50M $263.74M $263.74M $267.88M
-Cash and Cash Equivalents $214.42M $236.81M $235.05M $235.05M $232.19M
-Short Term Investments $59.67M $28.69M $28.69M $28.69M $35.69M
Receivables $267.19M $264.41M $278.85M $278.85M $262.16M
-Accounts Receivable $267.19M $264.41M $278.85M $278.85M $262.16M
Prepaid Assets $104.34M $97.71M $96.09M $96.09M $94.11M
Inventory $492.01M $495.04M $492.74M $492.74M $489.11M
Other Current Assets $53.86M $49.35M $28.13M $28.13M $30.33M
Total Non-Current Assets $2.37B $2.41B $2.44B $2.44B $2.50B
Net PPE $583.29M $584.08M $584.90M $584.90M $575.55M
-Gross PPE $583.29M $584.08M $1.03B $1.03B $575.55M
Goodwill and Other Intangible Assets $1.69B $1.72B $1.75B $1.75B $1.78B
-Goodwill $611.15M $613.25M $615.16M $615.16M $615.20M
-Other Intangible Assets $1.08B $1.11B $1.13B $1.13B $1.16B
Non-Current Deferred Assets $70.44M $68.08M $69.85M $69.85M $109.73M
Other Non-Current Assets $31.59M $34.96M $37.88M $37.88M $42.24M
Total Liabilities $2.52B $2.54B $2.56B $2.56B $2.61B
Total Current Liabilities $330.88M $346.85M $455.98M $455.98M $364.05M
Payables $85.87M $91.18M $99.38M $99.38M $92.31M
-Accounts Payable $82.64M $87.95M $95.73M $95.73M $92.31M
-Total Tax Payable $3.24M $3.24M $3.65M $3.65M –
Current Accrued Expenses $107.62M $133.32M $130.49M $130.49M $132.86M
Short-Term Debt and Capital Lease Obligation $57.51M $52.68M $140.57M $140.57M $52.58M
-Current Debt $43.59M $38.75M $126.55M $126.55M $38.75M
-Current Capital Lease Obligation $13.92M $13.93M $14.02M $14.02M $13.83M
Current Deferred Liabilities $11.70M $11.62M $11.46M $11.46M $11.33M
Total Non-Current Liabilities $2.19B $2.19B $2.10B $2.10B $2.24B
Long Term Debt and Capital Lease Obligation $1.99B $1.99B $1.89B $1.89B $1.95B
-Long Term Debt $1.83B $1.83B $1.73B $1.73B $1.79B
-Long Term Capital Lease Obligation $162.66M $160.12M $163.06M $163.06M $160.93M
Non-Current Deferred Liabilities $3.47M $6.14M $5.66M $5.66M $58.29M
Other Non-Current Liabilities $194.40M $195.56M $204.28M $204.28M $233.26M
Total Equity $1.04B $1.04B $1.04B $1.04B $1.04B
Stockholders' Equity $1.04B $1.04B $1.04B $1.04B $1.04B
Capital Stock $921,000.00 $922,000.00 $923,000.00 $923,000.00 $923,000.00
-Common Stock $921,000.00 $922,000.00 $923,000.00 $923,000.00 $923,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.35B $1.34B $1.34B $1.34B $1.33B
Retained Earnings $423.31M $418.82M $423.44M $423.44M $425.15M
Less: Treasury Stock $686.92M $687.12M $689.21M $689.21M $690.03M
Gains/Losses Not Affecting Retained Earnings -$40.20M -$30.94M -$30.08M -$30.08M -$31.98M
-Accumulated Depreciation – – -$443.95M -$443.95M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $22.80M $9.80M $50.38M $11.82M $40.91M
Net cash flow from continuing operations $22.80M $9.80M $50.38M $11.82M $40.91M
Net Income from Continuing Operations $4.48M -$4.62M -$516.47M -$1.70M -$5.40M
Gain/Loss from Continuing Operations $643,000.00 $90,000.00 $490,000.00 $0.00 -$4,000.00
Depreciation & Depletion & Amortization $38.14M $38.43M $151.83M $38.43M $38.52M
Deferred Tax -$4.33M $1.33M -$66.26M -$10.95M -$8.65M
Other Non-Cash Items $4.16M $32,000.00 -$15.41M -$4.45M -$13.43M
Change in Working Capital -$26.13M -$30.62M -$33.74M -$15.35M $24.30M
-Change in Receivables -$3.04M $13.65M -$485,000.00 -$16.45M $22.51M
-Change in Inventory $474,000.00 -$4.33M -$46.76M -$3.34M -$23.35M
-Change in Prepaid Assets -$7.44M -$21.88M -$2.80M $2.19M $16.22M
-Change in Payables and Accrued Expense -$15.20M -$19.19M $26.72M $23.02M $5.78M
-Change in Other Current Assets -$996,000.00 $1.39M $3.34M $8,000.00 $1.00M
-Change in Other Current Liabilities $836,000.00 $369,000.00 -$17.16M -$21.46M $1.76M
-Change In Other Working Capital -$762,000.00 -$630,000.00 $3.40M $685,000.00 $371,000.00
Net cash flow from investing -$43.28M -$14.85M -$108.06M -$34.91M -$15.59M
Net Cash Flow from Continuing Investing Activities -$43.28M -$14.85M -$108.06M -$34.91M -$15.59M
Net PPE Purchase and Sale -$12.31M -$14.85M -$81.44M -$17.21M -$15.16M
Net Investment Purchase and Sale -$30.98M $0.00 -$12.43M -$3.49M -$432,000.00
Financing Cash Flow -$818,000.00 $8.30M $28.34M $24.34M -$10.25M
Net Cash Flow from Continuing Financing Activities -$818,000.00 $8.30M $28.34M $24.34M -$10.25M
Net Issuance Payments Of Debt $6.51M $8.91M $50.81M $24.61M -$9.97M
Proceeds from Stock Option Exercised $0.00 $760,000.00 $957,000.00 $0.00 $0.00
Net Other Financing Charges -$7.33M -$1.38M -$23.21M -$271,000.00 -$274,000.00
Ending Cash Balance $214.42M $236.81M $235.05M $235.05M $232.19M
Net Change in Cash -$21.30M $3.25M -$29.34M $1.25M $15.07M
Beginning Cash Balance $236.81M $235.05M $246.38M $232.19M $217.91M
Effect of Exchange Rate Changes -$1.10M -$1.49M $18.02M $1.61M -$801,000.00
Free Cash Flow $10.50M -$5.05M -$45.25M -$19.60M $25.75M
Net Intangibles Purchase and Sale – – -$14.20M – –
Net Business Purchase and Sale – – $0.00 $0.00 –
Net Common Stock Issuance – – -$221,000.00 $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on IART.

Leave a comment

Scroll to Top